Sarepta Therapeutics | 4:持股变动声明-董事 Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 4:持股变动声明-董事 Boor Kathryn Jean
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 4:持股变动声明-高管 Rothfuss Cristin
Sarepta Therapeutics | 3:首次持股声明-高管 Rothfuss Cristin
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股变动声明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(4.6%)
Sarepta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Capital International Investors(6.7%)
Sarepta Therapeutics | 10-Q:2024财年三季报
Sarepta Therapeutics | 4:持股变动声明-董事 Connelly Deirdre P
Sarepta Therapeutics | 3:首次持股声明-董事 Connelly Deirdre P
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | 4:持股变动声明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股变动声明-高管 Estepan Ian Michael
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 4:持股变动声明-董事 Chambers Michael Andrew
Sarepta Therapeutics | S-8:员工福利计划证券登记
Sarepta Therapeutics | 10-Q:2024财年二季报
暂无数据